CWK · Cushman & Wakefield PLC - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $10.29B | $9.45B | $9.49B | $10.11B | $9.39B | $7.84B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $1.32B | $1.22B | $1.26B | $1.26B | $1.23B | $1.12B |
| Total Operating Expenses | $9.84B | $9.11B | $9.29B | $9.57B | $8.89B | $7.90B |
| D&A | $104.20M | $122.20M | $145.60M | $146.90M | $172.10M | $263.60M |
| Operating Income | $452.50M | $338.90M | $205.60M | $535.10M | $497.00M | ($53.10M) |
| Interest Expense | $216.20M | $229.90M | $281.10M | $193.10M | $179.50M | $163.80M |
| Income Tax | $26.00M | $44.50M | $5.40M | $141.60M | $89.90M | $43.90M |
| Net Income | $88.20M | $131.30M | ($35.40M) | $196.40M | $250.00M | ($220.50M) |
| EPS - Basic | $0.38 | $0.57 | ($0.16) | $0.87 | $1.12 | ($1.00) |
| EPS - Diluted | $0.38 | $0.56 | ($0.16) | $0.86 | $1.10 | ($1.00) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $784.20M | $793.30M | $767.70M | $644.50M | $770.70M | $1.07B |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | $2.84B | $2.69B | $2.80B | $2.77B | $2.83B | $2.89B |
| Total Assets | $7.68B | $7.55B | $7.77B | $7.95B | $7.89B | $7.34B |
| Current Liabilities | $2.59B | $2.33B | $2.40B | $2.39B | $2.43B | $2.07B |
| Long-term Debt | $2.62B | $2.94B | $3.10B | $3.21B | $3.22B | $3.24B |
| Total Liabilities | $5.72B | $5.79B | $6.10B | $6.29B | $6.44B | $6.24B |
| Stockholders' Equity | $1.96B | $1.75B | $1.68B | $1.66B | $1.45B | $1.09B |
| Retained Earnings | ($897.70M) | ($985.90M) | ($1.12B) | ($1.08B) | ($1.28B) | ($1.53B) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $340.40M | $208.00M | $152.20M | $49.10M | $549.50M | ($38.20M) |
| Investing Cash Flow | ($21.10M) | $81.20M | $48.90M | ($120.70M) | ($749.50M) | ($257.80M) |
| Financing Cash Flow | ($350.50M) | ($253.40M) | ($120.80M) | ($79.30M) | ($65.80M) | $571.90M |
| CapEx | $47.40M | $41.00M | $51.00M | $50.70M | $53.80M | $41.00M |
| Free Cash Flow | $293.00M | $167.00M | $101.20M | ($1.60M) | $495.70M | ($79.20M) |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 4.4% | 3.6% | 2.2% | 5.3% | 5.3% | -0.7% |
| EBITDA margin | 5.4% | 4.9% | 3.7% | 6.7% | 7.1% | 2.7% |
| Net margin | 0.9% | 1.4% | -0.4% | 1.9% | 2.7% | -2.8% |
| Free cash flow margin | 2.8% | 1.8% | 1.1% | -0.0% | 5.3% | -1.0% |
| FCF / Net income | 3.32 | 1.27 | -2.86 | -0.01 | 1.98 | 0.36 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 12.8% | 13.0% | 13.3% | 12.5% | 13.1% | 14.3% |
| Effective tax rate | 22.8% | 25.3% | - | 41.9% | 26.4% | - |
| Return on assets | 1.1% | 1.7% | -0.5% | 2.5% | 3.2% | -3.0% |
| Return on equity | 4.5% | 7.5% | -2.1% | 11.8% | 17.3% | -20.1% |
| Return on invested capital | 7.6% | 5.4% | 3.4% | 6.4% | 7.8% | -1.0% |
| Liquidity | ||||||
| Current ratio | 1.10 | 1.15 | 1.17 | 1.16 | 1.16 | 1.40 |
| Quick ratio | 1.10 | 1.15 | 1.17 | 1.16 | 1.16 | 1.40 |
| Cash ratio | 0.30 | 0.34 | 0.32 | 0.27 | 0.32 | 0.52 |
| Leverage | ||||||
| Debt / Equity | 1.34 | 1.68 | 1.85 | 1.93 | 2.22 | 2.96 |
| Debt / Assets | 0.34 | 0.39 | 0.40 | 0.40 | 0.41 | 0.44 |
| Debt / EBITDA | 4.72 | 6.38 | 8.82 | 4.71 | 4.81 | 15.37 |
| Interest coverage | 2.1x | 1.5x | 0.7x | 2.8x | 2.8x | -0.3x |
| Equity multiplier | 3.93 | 4.30 | 4.63 | 4.78 | 5.45 | 6.70 |
| Liabilities / Assets | 0.75 | 0.77 | 0.78 | 0.79 | 0.82 | 0.85 |
| Efficiency | ||||||
| Asset turnover | 1.34 | 1.25 | 1.22 | 1.27 | 1.19 | 1.07 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 42.6x | 23.4x | - | 14.5x | 20.2x | - |
| P / B | 1.9x | 1.7x | 1.5x | 1.7x | 3.5x | 3.0x |
| P / S | 0.4x | 0.3x | 0.3x | 0.3x | 0.5x | 0.4x |
| EV / EBITDA | 10.1x | 11.3x | 13.6x | 7.9x | 11.2x | 25.8x |
| Growth | ||||||
| Revenue growth (YoY) | 8.9% | -0.5% | -6.1% | 7.6% | 19.7% | 13.3% |
| Revenue CAGR (3y) | 0.6% | 0.2% | 6.6% | 13.4% | - | - |
| Revenue CAGR (5y) | 5.6% | 6.4% | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | 33.5% | 64.8% | -61.6% | 7.7% | - | - |
| Net income growth (YoY) | -32.8% | - | - | -21.4% | - | - |
| EPS growth (YoY) | -32.1% | - | - | -21.8% | - | 35.1% |
| EPS CAGR (3y) | -23.8% | -20.2% | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | 75.4% | 65.0% | - | - | - | - |
| FCF CAGR (5y) | - | -2.4% | - | - | - | - |
| Book value growth (YoY) | 11.4% | 4.6% | 1.0% | 14.7% | 32.3% | -15.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$10.29B totalAmericas Segment$7.51B · 73.0%
Asia Pacific Segment$1.71B · 16.6%
Europe The Middle East And Africa Segment$1.07B · 10.4%
Product / service
$7.51B totalService$4.96B · 66.1%
Leasing Service$1.70B · 22.6%
Capital Markets Service$668.00M · 8.9%
Valuation And Other Service$183.30M · 2.4%
Geographic
$10.29B totalUS$7.08B · 68.8%
All Countries Excluding United States Australia Singapore$2.29B · 22.2%
AU$501.80M · 4.9%
SG$420.70M · 4.1%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.59
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
6/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Real Estate
Comparing Cushman & Wakefield plc against the 5 most active filers in the same SIC group.